IGF2BP3 expression is elevated in colon cancers and was shown to be associated with increased tumor angiogenesis, growth, and poor prognosis (Lochhead et al. 2012; Shantha Kumara et al. 2015; Xu et al. 2019; Yang et al. 2020). Here, IGF2BP3 is linked to malignant colon neoplasm.